Reduced silent information regulator 1 signaling exacerbates myocardial ischemia-reperfusion injury in type 2 diabetic rats and the protective effect of melatonin

Journal of Pineal Research

Volumn 59, Issue 3, 2015, Pages 376-390

  Yu, Liming ^a   Liang, Hongliang ^a   Dong, Xiaochao ^a   Zhao, Guolong ^b   Jin, Zhenxiao ^a   Zhai, Mengen ^a   Yang, Yang ^c   Chen, Wensheng ^a   Liu, Jincheng ^a   Yi, Wei ^a   Yang, Jian ^a   Yi, Dinghua ^a   Duan, Weixun ^a   Yu, Shiqiang ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b NINGXIA MEDICAL UNIVERSITY   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

endoplasmic reticulum stress; melatonin; myocardial ischemia reperfusion; oxidative stress; silent information regulator 1 signaling; type 2 diabetes mellitus

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; GLUCOSE; GLYCOPROTEIN GP 91; INITIATION FACTOR 2ALPHA; MALONALDEHYDE; MELATONIN; SILENT INFORMATION REGULATOR 1; SILENT INFORMATION REGULATOR PROTEIN; SIRTINOL; SIRTUIN 1; STREPTOZOCIN; SUPEROXIDE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; BENZAMIDE DERIVATIVE; NAPHTHOL DERIVATIVE; SIRT1 PROTEIN, RAT;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; ENDOPLASMIC RETICULUM STRESS; HEART INFARCTION; HEART INJURY; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; LIPID DIET; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; GENETICS; METABOLISM; MYOCARDIAL REPERFUSION INJURY; PHYSIOLOGY;

ANIMALS; BENZAMIDES; DIABETES MELLITUS, EXPERIMENTAL; MALE; MELATONIN; MYOCARDIAL REPERFUSION INJURY; NAPHTHOLS; OXIDATIVE STRESS; RATS; SIGNAL TRANSDUCTION; SIRTUIN 1;

EID: 84942195926     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/jpi.12269     Document Type: Article

References (74)

1. Chen L, Magliano DJ, Zimmet PZ,. The worldwide epidemiology of type 2 diabetes mellitus-present and future perspectives. Nat Rev Endocrinol 2012; 8: 228-236.
2. Devereux RB, Roman MJ, Paranicas M, et al., Impact of diabetes on cardiac structure and function: the strong heart study. Circulation 2000; 101: 2271-2276.
3. Huynh K, Bernardo BC, McMullen JR, et al., Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways. Pharmacol Ther 2014; 142: 375-415.
4. Forrat R, Sebbag L, Wiernsperger N, et al., Acute myocardial infarction in dogs with experimental diabetes. Cardiovasc Res 1993; 27: 1908-1912.
5. Di Filippo C, Marfella R, Cuzzocrea S, et al., Hyperglycemia in streptozotocin-induced diabetic rat increases infarct size associated with low levels of myocardial HO-1 during ischemia/reperfusion. Diabetes 2005; 54: 803-810.
6. Koka S, Das A, Salloum FN, et al., Phosphodiesterase-5 inhibitor tadalafil attenuates oxidative stress and protects against myocardial ischemia/reperfusion injury in type 2 diabetic mice. Free Radic Biol Med 2013; 60: 80-88.
7. Huynh K, Kiriazis H, Du XJ, et al., Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes. Diabetologia 2012; 55: 1544-1553.
8. Reiter RJ, Tan DX,. Melatonin: a novel protective agent against oxidative injury of the ischemic/reperfused heart. Cardiovasc Res 2003; 58: 10-19.
9. Tengattini S, Reiter RJ, Tan DX, et al., Cardiovascular diseases: protective effects of melatonin. J Pineal Res 2008; 44: 16-25.
10. Hardeland R,. Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance. Endocrine 2005; 27: 119-130.
11. Tomas-Zapico C, Coto-Montes A,. A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes. J Pineal Res 2005; 39: 99-104.
12. Suzen S, Bozkaya P, Coban T, et al., Investigation of the in vitro antioxidant behaviour of some 2-phenylindole derivatives: discussion on possible antioxidant mechanisms and comparison with melatonin. J Enzyme Inhib Med Chem 2006; 21: 405-411.
13. Yeung HM, Hung MW, Lau CF, et al., Cardioprotective effects of melatonin against myocardial injuries induced by chronic intermittent hypoxia in rats. J Pineal Res 2015; 58: 12-25.
14. Yu L, Sun Y, Cheng L, et al., Melatonin receptor-mediated protection against myocardial ischemia/reperfusion injury: role of SIRT1. J Pineal Res 2014; 57: 228-238.
15. Yang Y, Duan W, Jin Z, et al., JAK2/STAT3 activation by melatonin attenuates the mitochondrial oxidative damage induced by myocardial ischemia/reperfusion injury. J Pineal Res 2013; 55: 275-286.
16. Amin AH, El-Missiry MA, Othman AI,. Melatonin ameliorates metabolic risk factors, modulates apoptotic proteins, and protects the rat heart against diabetes-induced apoptosis. Eur J Pharmacol 2015; 747: 166-173.
17. Nduhirabandi F, Du Toit EF, Blackhurst D, et al., Chronic melatonin consumption prevents obesity-related metabolic abnormalities and protects the heart against myocardial ischemia and reperfusion injury in a prediabetic model of diet-induced obesity. J Pineal Res 2011; 50: 171-182.
18. Karbownik M, Reiter RJ,. Antioxidative effects of melatonin in protection against cellular damage caused by ionizing radiation. Proc Soc Exp Biol Med 2000; 225: 9-22.
19. Yang Y, Sun Y, Yi W, et al., A review of melatonin as a suitable antioxidant against myocardial ischemia-reperfusion injury and clinical heart diseases. J Pineal Res 2014; 57: 357-366.
20. Genade S, Genis A, Ytrehus K, et al., Melatonin receptor-mediated protection against myocardial ischaemia/reperfusion injury: role of its anti-adrenergic actions. J Pineal Res 2008; 45: 449-458.
21. Yang Y, Duan W, Li Y, et al., Novel role of silent information regulator 1 in myocardial ischemia. Circulation 2013; 128: 2232-2240.
22. Guo R, Liu W, Liu B, et al., SIRT1 suppresses cardiomyocyte apoptosis in diabetic cardiomyopathy: an insight into endoplasmic reticulum stress response mechanism. Int J Cardiol 2015; 191: 36-45.
23. Yang Y, Duan W, Lin Y, et al., SIRT1 activation by curcumin pretreatment attenuates mitochondrial oxidative damage induced by myocardial ischemia reperfusion injury. Free Radic Biol Med 2013; 65: 667-679.
24. Hsu CP, Zhai P, Yamamoto T, et al., Silent information regulator 1 protects the heart from ischemia/reperfusion. Circulation 2010; 122: 2170-2182.
25. Makino N, Maeda T, Oyama J, et al., Improving insulin sensitivity via activation of PPAR-gamma increases telomerase activity in the heart of OLETF rats. Am J Physiol Heart Circ Physiol 2009; 297: H2188-H2195.
26. Sulaiman M, Matta MJ, Sunderesan NR, et al., Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol 2010; 298: H833-H843.
27. Koka S, Aluri HS, Xi L, et al., Chronic inhibition of phosphodiesterase 5 with tadalafil attenuates mitochondrial dysfunction in type 2 diabetic hearts: potential role of NO/SIRT1/PGC-1alpha signaling. Am J Physiol Heart Circ Physiol 2014; 306: H1558-H1568.
28. Shi Z, Fu F, Yu L, et al., Vasonatrin peptide attenuates myocardial ischemia-reperfusion injury in diabetic rats and underlying mechanisms. Am J Physiol Heart Circ Physiol 2015; 308: H281-H290.
29. Yu L, Li F, Zhao G, et al., Protective effect of berberine against myocardial ischemia reperfusion injury: role of Notch1/Hes1-PTEN/Akt signaling. Apoptosis 2015; 20: 796-810.
30. Kaur H, Kumar A, Jaggi AS, et al., Pharmacologic investigations on the role of Sirt-1 in neuroprotective mechanism of postconditioning in mice. J Surg Res 2015; 197: 191-200.
31. Agil A, El-Hammadi M, Jimenez-Aranda A, et al., Melatonin reduces hepatic mitochondrial dysfunction in diabetic obese rats. J Pineal Res 2015; 59: 70-79.
32. Kireev R, Bitoun S, Cuesta S, et al., Melatonin treatment protects liver of Zucker rats after ischemia/reperfusion by diminishing oxidative stress and apoptosis. Eur J Pharmacol 2013; 701: 185-193.
33. Yan W, Zhang H, Liu P, et al., Impaired mitochondrial biogenesis due to dysfunctional adiponectin-AMPK-PGC-1alpha signaling contributing to increased vulnerability in diabetic heart. Basic Res Cardiol 2013; 108: 329.
34. Duan W, Yang Y, Yi W, et al., New role of JAK2/STAT3 signaling in endothelial cell oxidative stress injury and protective effect of melatonin. PLoS ONE 2013; 8: e57941.
35. Zhao J, Young YK, Fradette J, et al., Melatonin pretreatment of human adipose tissue-derived mesenchymal stromal cells enhances their pro-survival and protective effects on human kidney cells. Am J Physiol Renal Physiol 2015; 308: F1474-F1483.
36. Zhou L, Chen X, Liu T, et al., Melatonin reverses H2 O2 -induced premature senescence in mesenchymal stem cells via the SIRT1-dependent pathway. J Pineal Res 2015; 59: 190-205.
37. Preis SR, Pencina MJ, Hwang SJ, et al., Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the Framingham Heart Study. Circulation 2009; 120: 212-220.
38. Berry C, Tardif JC, Bourassa MG,. Coronary heart disease in patients with diabetes: part II: recent advances in coronary revascularization. J Am Coll Cardiol 2007; 49: 643-656.
39. Aronson D, Edelman ER,. Coronary artery disease and diabetes mellitus. Cardiol Clin 2014; 32: 439-455.
40. Go AS, Mozaffarian D, Roger VL, et al., Executive summary: heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 2014; 129: 399-410.
41. Donahoe SM, Stewart GC, McCabe CH, et al., Diabetes and mortality following acute coronary syndromes. JAMA 2007; 298: 765-775.
42. Aronson D, Rayfield EJ, Chesebro JH,. Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction. Ann Intern Med 1997; 126: 296-306.
43. Varga ZV, Giricz Z, Liaudet L, et al., Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy. Biochim Biophys Acta 2015; 1852: 232-242.
44. Stratmann B, Worms J, Tschoepe D,. Diabetic cardiomyopathy/heart failure: news regarding etiology, diagnosis, therapy. Dtsch Med Wochenschr 2014; 139: 2006-2009.
45. Ding W, Yang L, Zhang M, et al., Reactive oxygen species-mediated endoplasmic reticulum stress contributes to aldosterone-induced apoptosis in tubular epithelial cells. Biochem Biophys Res Commun 2012; 418: 451-456.
46. Ferber S, Halkin A, Cohen H, et al., Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat Med 2000; 6: 568-572.
47. Whitton PD, Hems DA,. Glycogen synthesis in the perfused liver of streptozotocin-diabetic rats. Biochem J 1975; 150: 153-165.
48. Grubisha O, Smith BC, Denu JM,. Small molecule regulation of Sir2 protein deacetylases. FEBS J 2005; 272: 4607-4616.
49. Chong ZZ, Wang S, Shang YC, et al., Targeting cardiovascular disease with novel SIRT1 pathways. Future Cardiol 2012; 8: 89-100.
50. Luo XY, Qu SL, Tang ZH, et al., SIRT1 in cardiovascular aging. Clin Chim Acta 2014; 437: 106-114.
51. Brunet A, Sweeney LB, Sturgill JF, et al., Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 2004; 303: 2011-2015.
52. Bordone L, Motta MC, Picard F, et al., Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic beta cells. PLoS Biol 2006; 4: e31.
53. Lee JH, Song MY, Song EK, et al., Overexpression of SIRT1 protects pancreatic beta-cells against cytokine toxicity by suppressing the nuclear factor-kappaB signaling pathway. Diabetes 2009; 58: 344-351.
54. Gerhart-Hines Z, Rodgers JT, Bare O, et al., Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha. EMBO J 2007; 26: 1913-1923.
55. Picard F, Kurtev M, Chung N, et al., Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 2004; 429: 771-776.
56. Vahtola E, Louhelainen M, Merasto S, et al., Forkhead class O transcription factor 3a activation and Sirtuin1 overexpression in the hypertrophied myocardium of the diabetic Goto-Kakizaki rat. J Hypertens 2008; 26: 334-344.
57. Vahtola E, Louhelainen M, Forsten H, et al., Sirtuin1-p53, forkhead box O3a, p38 and post-infarct cardiac remodeling in the spontaneously diabetic Goto-Kakizaki rat. Cardiovasc Diabetol 2010; 9: 5.
58. Reiter RJ, Tan DX, Manchester LC, et al., Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence. Cell Biochem Biophys 2001; 34: 237-256.
59. Giacco F, Brownlee M,. Oxidative stress and diabetic complications. Circ Res 2010; 107: 1058-1070.
60. Zephy D, Ahmad J,. Type 2 diabetes mellitus: role of melatonin and oxidative stress. Diabetes Metab Syndr 2015; 9: 127-131.
61. Lardone PJ, Alvarez-Sanchez SN, Guerrero JM, et al., Melatonin and glucose metabolism: clinical relevance. Curr Pharm Des 2014; 20: 4841-4853.
62. Xu J, Zhou Q, Xu W, et al., Endoplasmic reticulum stress and diabetic cardiomyopathy. Exp Diabetes Res 2012; 2012: 827971.
63. Guo W, Jiang T, Lian C, et al., QKI deficiency promotes FoxO1 mediated nitrosative stress and endoplasmic reticulum stress contributing to increased vulnerability to ischemic injury in diabetic heart. J Mol Cell Cardiol 2014; 75: 131-140.
64. Tunon MJ, San-Miguel B, Crespo I, et al., Melatonin treatment reduces endoplasmic reticulum stress and modulates the unfolded protein response in rabbits with lethal fulminant hepatitis of viral origin. J Pineal Res 2013; 55: 221-228.
65. Kim SJ, Kang HS, Lee JH, et al., Melatonin ameliorates ER stress-mediated hepatic steatosis through miR-23a in the liver. Biochem Biophys Res Commun 2015; 458: 462-469.
66. Carloni S, Albertini MC, Galluzzi L, et al., Melatonin reduces endoplasmic reticulum stress and preserves sirtuin 1 expression in neuronal cells of newborn rats after hypoxia-ischemia. J Pineal Res 2014; 57: 192-199.
67. Peschke E, Frese T, Chankiewitz E, et al., Diabetic Goto Kakizaki rats as well as type 2 diabetic patients show a decreased diurnal serum melatonin level and an increased pancreatic melatonin-receptor status. J Pineal Res 2006; 40: 135-143.
68. von Gall C, Lewy A, Schomerus C, et al., Transcription factor dynamics and neuroendocrine signalling in the mouse pineal gland: a comparative analysis of melatonin-deficient C57BL mice and melatonin-proficient C3H mice. Eur J Neurosci 2000; 12: 964-972.
69. Abbott SM, Zee PC,. Melatonin level and risk for type 2 diabetes. JAMA 2013; 310: 536-537.
70. McMullan CJ, Schernhammer ES, Rimm EB, et al., Melatonin secretion and the incidence of type 2 diabetes. JAMA 2013; 309: 1388-1396.
71. Rezzani R, Rodella LF, Bonomini F, et al., Beneficial effects of melatonin in protecting against cyclosporine A-induced cardiotoxicity are receptor mediated. J Pineal Res 2006; 41: 288-295.
72. Wiechmann AF, Sherry DM,. Melatonin receptors are anatomically organized to modulate transmission specifically to cone pathways in the retina of Xenopus laevis. J Comp Neurol 2012; 520: 1115-1127.
73. Sheynzon P, Korf HW,. Targeted deletions of Mel1a and Mel1b melatonin receptors affect pCREB levels in lactotroph and pars intermedia cells of mice. Neurosci Lett 2006; 407: 48-52.
74. Petit L, Lacroix I, de Coppet P, et al., Differential signaling of human Mel1a and Mel1b melatonin receptors through the cyclic guanosine 3′-5′-monophosphate pathway. Biochem Pharmacol 1999; 58: 633-639.